Delivery Order SPE2DB20D2104-SPE2DB25FMNAD
Award Date
4/9/25
Potential Completion Date
4/10/25
Potential Value
$3.6K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,821.22, is for the delivery of LUMIGAN 0.01% eye drops in 5ml bottles. The award is a Firm Fixed Price Delivery Order with a completion date of June 7, 2024. This contract is not designated as a set-aside. Amerisourcebergen is the prime contractor, and the contract is part of a larger Indefinite...
This federal contract award is for the delivery of LUMIGAN 0.01% eye drops, 2.5 ml, to the Defense Logistics Agency (DLA). The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, and has a ceiling value of $2,210.74. The contract is a delivery order, with a firm fixed price, and has an ultimate completion date of August 15, 2024. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,962.10 firm-fixed-price delivery order is for the supply of LUMIGAN 0.01% eye drops, a medication used to treat glaucoma. The contract has an ultimate completion date of April 18, 2025 and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the...
This federal contract award is for the delivery of LUMIGAN 0.01% eye drops, a pharmaceutical product, to the Defense Logistics Agency (DLA). The award, valued at $1,457.37, was made to the prime contractor AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract has an ultimate completion date of October 21, 2024 and is a firm fixed-price delivery order. It is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award, valued at $3,631.26, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of LUMIGAN 0.01% eye drops, a specialty pharmaceutical product, to support military healthcare programs. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of July 17, 2024. It is not designated with a set-aside requirement,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,741.16, is for the supply of LUMIGAN 0.01% eye drops in 5 ML containers. The contract is a firm fixed-price delivery order and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of LUMIGAN 0.01% eye drops, a specialty medication. The contract has a ceiling value of $1,641.68 and runs through February 28, 2025. It is a firm fixed-price contract, with no set-aside designation indicated. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with...
This is a $3,391.99 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the procurement of LUMIGAN 0.01% eye drops, a specialty ophthalmic medication, in support of federal healthcare programs. The contract has an ultimate completion date of June 13, 2024. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC)...
This is a federal contract award by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. for the supply of LUMIGAN 0.01% eye drops in 5ml containers. The contract is a Delivery Order with a Firm Fixed Price of $9,539.84 and an ultimate completion date of November 19, 2024. The contract is not set aside for any specific business type. AmerisourceBergen Drug Corp. is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, with a ceiling value of $2,552.17, is for the delivery of LUMIGAN 0.01% eye drops with an ultimate completion date of June 5, 2024. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop...